{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-050913","form_type":"8-K","ticker":"BJDX","cik":"0001704287","company_name":"Bluejay Diagnostics, Inc.","filed_at":"2025-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.402324+00:00","generated_at":"2026-05-20T00:00:41.944720+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bluejay Diagnostics mid-year update: cash $5.7M, headcount cut to 5, seeks $30M+ funding","bullets":["SYMON-II pivotal sepsis trial enrolling; 510(k) submission planned for Q4 2027, FDA approval target Q3 2028.","Cash & equivalents $5.7M as of April 30, 2025; Q1 2025 net loss $1.9M, FY2024 net loss $7.7M.","April 2025 private placement raised $3.8M gross; company aims to raise at least $30M total through FY2027.","Workforce reduced to 5 employees after CTO departure; cost-saving measures implemented.","Annual meeting June 18, 2025: board to shrink from 6 to 5, reverse stock split proposals to maintain Nasdaq listing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-050913","json":"https://secwatch.observer/filing/0001213900-25-050913.json","markdown":"https://secwatch.observer/filing/0001213900-25-050913.md","text":"https://secwatch.observer/filing/0001213900-25-050913.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704287/000121390025050913/0001213900-25-050913-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704287/000121390025050913/ea0244646-8k_bluejay.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T00:00:41.944720+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}